Jun 12, 2020
Sun Pharma Presents ODOMZO® and LEVULAN® KERASTICK® + BLU-U® Data, Offering Clinical Insights for Treating People with or at Risk of Skin Cancer
Apr 08, 2020
Sirnaomics Announces Positive Topline Results from Interim Analysis of Ongoing Phase II Clinical Trial Evaluating STP705 in Cutaneous Squamous Cell Carcinoma in situ (isSCC)
Feb 17, 2020
Basal Cell Carcinoma Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025
Jan 07, 2020
3Derm announces two FDA Breakthrough Device designations for autonomous skin cancer AI
Dec 18, 2019
Investigator-initiated Phase II Clinical Study of Remetinostat Started in Patients With Squamous Cell Carcinoma
Dec 04, 2019
Brachytherapy Proves Effective in Treating Skin Cancer
Jun 19, 2019
Global Basal Cell Carcinoma Market Spotlight 2019: Key Marketed and Pipeline Drugs, Epidemiology, Clinical Trials, Patents, Licensing and Acquisition Deals, Revenue Forecasts
May 13, 2019
Positive Data From The Remetinostat Phase II Study in Basal Cell Carcinoma Presented at SID Annual meeting
May 07, 2019
Data From the Remetinostat Phase II Study in Basal Cell Carcinoma Patients to be Presented at the 2019 SID Annual Meeting
Apr 24, 2019
Xstrahl Introduces One-Stop Shop Treatment System for Non-Melanoma Skin Cancer
Apr 17, 2019
Senhwa Biosciences Silmitasertib / Basal Cell Carcinoma Trial Completed 1st Patient Enrollment
Feb 12, 2019
Cure Rate Exceeds 97 Percent in Retrospective Study of Sensus Healthcare's SRT-100(TM) for Treating Basal and Squamous Cell Carcinomas of the Lower Extremities
Feb 07, 2019
Trinity Dermatology, Now a Part of U.S. Dermatology Partners, Begins Offering Mohs Surgery in Carrollton, Texas
Jan 24, 2019
Cutaneous Squamous Cell Carcinoma (cSCC) Market Insights, Epidemiology and Market Forecasts, 2016-2018 & 2027
Nov 14, 2018
Dermatology Specialist Dr. Richard Torbeck with Advanced Dermatology PC Offers Overview of Precise Skin Cancer Surgery and Tips on Who Benefits Most
Nov 05, 2018
Global Basal Cell Carcinoma Market and Competitive Landscape Report 2018
Nov 01, 2018
Senhwa Biosciences Silmitasertib filed IND of Basal Cell Carcinoma approved by FDA
Oct 11, 2018
HedgePath Pharmaceuticals to Present at the 2018 BioFlorida Annual Conference
Sep 12, 2018
The Dark Side of the Hottest Summer in a Century: 'The High Rate of Skin Cancer Among Outdoor Workers can be Expected to Increase Still Further'
Aug 06, 2018
HedgePath Pharmaceuticals Announces Positive FDA Feedback from FDA Type-C Meeting and Files Pre-NDA Meeting Request